Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 25, 2022

Pharmadax Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PHARMADAX INC, and what generic and branded alternatives to PHARMADAX INC drugs are available?

PHARMADAX INC has six approved drugs.

Summary for Pharmadax Inc

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	6

Drugs and US Patents for Pharmadax Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmadax Inc	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	214423-002	Jan 4, 2022	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Pharmadax Inc	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	203699-001	Mar 30, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Pharmadax Inc	ENTECAVIR	entecavir	TABLET;ORAL	212106-002	Aug 10, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Pharmadax Inc	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	203028-001	Mar 31, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Pharmadax Inc	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	201464-001	May 25, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Harvard Business School

AstraZeneca

Dow

Moodys

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.